Journey in antithrombotic strategies for ST-elevation myocardial infarction

Gordon L. Chen, Chunming Dong, Pascal Goldschmidt-Clermont

Research output: Contribution to journalArticle

Abstract

Our understanding and treatment of the ST-elevation myocardial infarction (STEMI) has led to a tremendous improvement in the care and preservation of life affecting millions yearly. As the medical community continues to discover novel strategies in therapeutics and innovations in prevention, it is imperative to understand the scientific journey the treatment of STEMI has traveled. Furthermore, the research pillars that led to our understanding of the current paradigm of STEMI will be highlighted in an effort to illuminate the foundation on which we now stand.

Original languageEnglish
Pages (from-to)235-242
Number of pages8
JournalCritical Pathways in Cardiology
Volume9
Issue number4
DOIs
StatePublished - Dec 1 2010

Fingerprint

Research
ST Elevation Myocardial Infarction
Therapeutics

Keywords

  • bone marrow progenitor
  • STEMI
  • treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Journey in antithrombotic strategies for ST-elevation myocardial infarction. / Chen, Gordon L.; Dong, Chunming; Goldschmidt-Clermont, Pascal.

In: Critical Pathways in Cardiology, Vol. 9, No. 4, 01.12.2010, p. 235-242.

Research output: Contribution to journalArticle

Chen, Gordon L. ; Dong, Chunming ; Goldschmidt-Clermont, Pascal. / Journey in antithrombotic strategies for ST-elevation myocardial infarction. In: Critical Pathways in Cardiology. 2010 ; Vol. 9, No. 4. pp. 235-242.
@article{cfe1644f5efe48789567e51763643939,
title = "Journey in antithrombotic strategies for ST-elevation myocardial infarction",
abstract = "Our understanding and treatment of the ST-elevation myocardial infarction (STEMI) has led to a tremendous improvement in the care and preservation of life affecting millions yearly. As the medical community continues to discover novel strategies in therapeutics and innovations in prevention, it is imperative to understand the scientific journey the treatment of STEMI has traveled. Furthermore, the research pillars that led to our understanding of the current paradigm of STEMI will be highlighted in an effort to illuminate the foundation on which we now stand.",
keywords = "bone marrow progenitor, STEMI, treatment",
author = "Chen, {Gordon L.} and Chunming Dong and Pascal Goldschmidt-Clermont",
year = "2010",
month = "12",
day = "1",
doi = "10.1097/HPC.0b013e31820303ff",
language = "English",
volume = "9",
pages = "235--242",
journal = "Critical Pathways in Cardiology",
issn = "1535-282X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Journey in antithrombotic strategies for ST-elevation myocardial infarction

AU - Chen, Gordon L.

AU - Dong, Chunming

AU - Goldschmidt-Clermont, Pascal

PY - 2010/12/1

Y1 - 2010/12/1

N2 - Our understanding and treatment of the ST-elevation myocardial infarction (STEMI) has led to a tremendous improvement in the care and preservation of life affecting millions yearly. As the medical community continues to discover novel strategies in therapeutics and innovations in prevention, it is imperative to understand the scientific journey the treatment of STEMI has traveled. Furthermore, the research pillars that led to our understanding of the current paradigm of STEMI will be highlighted in an effort to illuminate the foundation on which we now stand.

AB - Our understanding and treatment of the ST-elevation myocardial infarction (STEMI) has led to a tremendous improvement in the care and preservation of life affecting millions yearly. As the medical community continues to discover novel strategies in therapeutics and innovations in prevention, it is imperative to understand the scientific journey the treatment of STEMI has traveled. Furthermore, the research pillars that led to our understanding of the current paradigm of STEMI will be highlighted in an effort to illuminate the foundation on which we now stand.

KW - bone marrow progenitor

KW - STEMI

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=78650366532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650366532&partnerID=8YFLogxK

U2 - 10.1097/HPC.0b013e31820303ff

DO - 10.1097/HPC.0b013e31820303ff

M3 - Article

VL - 9

SP - 235

EP - 242

JO - Critical Pathways in Cardiology

JF - Critical Pathways in Cardiology

SN - 1535-282X

IS - 4

ER -